Do drug holidays and CTX testing help reduce BONJ risk?
Bisphosphonate-associated osteonecrosis of the jaw (BONJ) is a rare condition, but patients on long-term bisphosphonate therapy are still at risk for it. So is there anything that can be done to mitigate this risk? An expert panel discussed the issue of osteonecrosis of the jaw during a presentation on Friday at the 2012 ADA Annual Session. An expert panel discussed the issue of osteonecrosis of the jaw during a presentation

